Family stem cells tested against deadly pancreatic cancer
NCT ID NCT04087889
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tested stem cells taken from a patient's blood relative to treat pancreatic cancer, a fast-growing and often deadly disease. Only one patient was treated under a special expanded access program, which is now closed. The goal was to see if these donated stem cells could help control the cancer and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stem cells from a blood relative
- What this could lead to
- If it works, this could point toward a new way to treat pancreatic cancer using stem cells from a family member.
- What could go wrong
- This was a single-patient trial that is no longer available, so results are very limited. Stem cell treatments for cancer are still experimental and may not work or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?
- Can a pill rouse the immune system against pancreatic cancer?